BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Mar 18, 2002
 |  BC Week In Review  |  Company News  |  Deals

Amersham, Pharmacia, University of Washington deal

PHA will sell to AHM its 45% holding in Amersham Biosciences plc (Little Chalfont, U.K.) for L704 million ($1 billion) in cash, giving AHM 100% ownership of the joint venture. Amersham Biosciences, formerly...

Read the full 143 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >